Tianjin Pharmaceutical Da Re Tang Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 600329-SS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2001) — listing | $262,096 7.1× | $375,857 7.0× |
| Year 6 (2006) | $147,534 5.0× | $215,573 4.9× |
| Year 11 (2011) | $64,817 2.9× | $95,579 2.9× |
| Year 16 (2016) | $35,456 2.3× | $52,110 2.3× |
| Year 21 (2021) | $12,139 1.5× | $17,958 1.5× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Popular scenarios with 600329
For illustration only — not investment advice. Past performance is not indicative of future results.